Course Overview: Cardiovascular PET: Moving into F-18 Myocardial Perfusion Imaging – Insights from Experts-Projecting the Impact of F-18 MPI Tracers on Hybrid Imaging and Expansion Cardiac PET Worldwide

Projecting the Impact of F-18 MPI Tracers on Hybrid Imaging and Expansion Cardiac PET Worldwide

Video Transcription

Video Summary

Dr. Muaz Elmela discusses the potential impact of a new tracer on the global use of cardiac PET scans. Currently, the United States accounts for 92% of all PET scans worldwide, leaving many patients in other countries without access to this important diagnostic tool. The new tracer, which can be used with low-volume PET sites, has the potential to expand cardiac PET utilization, particularly in countries where access is currently limited. However, widespread adoption will require significant training and support for healthcare professionals in these countries. The use of PET scans in cardiac diagnostics is growing in importance, especially considering recent guidelines emphasizing the value of PET over SPECT imaging. While exercise testing is generally recommended, the ability to assess myocardial blood flow is the key advantage of PET scans and should not be sacrificed in protocol development. Overall, the introduction of this new tracer has the potential to greatly benefit patients globally by increasing access to cardiac PET scans.

Asset Caption

Expert Insights by speaker Mouaz Al-Mallah, MD, MSc, MASNC

Keywords

Dr. Muaz Elmela

new tracer

cardiac PET scans

global impact

accessibility